Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

Abstract

Compared with use of other second or third line antidiabetic drugs, use of DPP-4 inhibitors, and possibly GLP-1 receptor agonists, might be associated with an increased risk of cholangiocarcinoma in adults with type 2 diabetes.